The development of novel therapeutics in the field of spinal neurosurgery faces a litany of
translational challenges. Achieving precise drug targeting within the confined spaces …

Objective This study was designed to evaluate the postoperative pain effect and clinical
efficacy of different drugs combined with PKP or PVP in treating osteoporotic vertebral …

Background: Teriparatide is an anabolic agent for osteoporosis and is believed to improve
the bone healing process. Previous studies showed that teriparatide could enhance not only …

Background: The incidence of osteoporosis is a prime concern, especially in parts of the
world where the population is aging, such as Europe or the US. Many new therapy …

We describe a case of L2 vertebral burst fracture in a 40-year-old male patient without any
other comorbidities due to a ground-fall from horse. Despite surgical intervention with L1-L3 …

Sažetak Cilj istraživanja: Primjena lijekova izvan odobrenih uvjeta važan je dio legitimne
medicinske prakse u cijelom svijetu, s obzirom da učinkoviti odobreni lijekovi ponekad mogu …

Teriparatide is an FDA-approved medication for osteoporosis that presents promising results
in treating various musculoskeletal conditions. It helps in improving the bone mineral density …

特立帕肽治疗骨质疏松合并腰椎退行性变经椎间融合后骨融合率的系统评价 Page 1 Chinese
Journal of Tissue Engineering Research|Vol 27|No.9|March 2023|1427 **组织工程研究 …

OBJECTIVE: To systematically review the changes of bone fusion rate after interbody fusion
in patients with osteoporosis and lumbar degenerative disease treated with teriparatide …